Back to journals
Academic Journal

Brain Behavior and Immunity - Health

2 Papers Indexed in Blossom

Data updated

Research Footprint

Brain Behavior and Immunity - Health has 2 tracked papers indexed in Blossom (2021–2023) from 10 authors, most often covering Psilocybin and Ketamine, across Depressive Disorders, Immunology & Inflammation and Healthy Volunteers.

Published Papers

Paywallindividual

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study

This double-blind placebo-controlled paper (n=60) explores the effects psilocybin (12mg/70kg) has on a range of inflammatory markers associated with stress-related psychiatric disorders. Blood samples, MRI and questionnaires were used to assess different aspects of the immune response. Psilocybin immediately reduced levels of the inflammation-inducing TNF-α while other markers were unchanged. After seven days, TNF-α returned to baseline while levels of IL-6 and CRP were reduced in the psilocybin group, which were associated with more persisting positive mood and social effects.

Published
Journal
Brain Behavior and Immunity - Health
Authors
Mason, N. L., Szabo, A., Kuypers, K. P. C., Mallaroni, P., de la Torre, R., Reckweg, J., Tse, D. H. Y., Hutten, N. P. W., Ramaekers, J. G.
Open Accessmeta

Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency

This review (2021) explores the anti-inflammatory properties of ketamine and how they relate to its antidepressant effects. A case is made for using ketamine for psychiatric emergencies due to its dual effect on both inflammation and depressive symptoms. Ketamine may be a successful and personalized treatment of inflammatory-induced TRD and suicidal thoughts and behaviour.

Published
Journal
Brain Behavior and Immunity - Health
Authors
Nikkheslat, N.

Quick Facts

Papers Indexed
2
h-Index
35
Publisher
Elsevier
Website
Visit